Johnson & Johnson has been a stalwart of health care and consumer goods for more than a century, but its rank as a Fortune 500 company hasn’t stopped it from reinvention.
In 2011, changes in the company’s pharmaceutical division left its 300,000-square-foot San Diego R&D facility with vacant offices. Instead of moving more employees in, it saw an opportunity to try a radical idea, and devoted the extra space to a pilot program it had been considering: an in-house biotech incubator, with no strings attached. Called JLabs, it was a pioneer among such programs. Startups developing new cancer treatments or wireless health care devices get to lease the lab equipment they need, without having to turn over any stake in their business.
Why would such a large corporation, especially in a complex industry flush with intellectual property laws, give anyone a leg up?
“Our commitment is to help accelerate the rate at which lifesaving medicines and technologies move from bench to bedside and into the hands of patients who need them,” says Kara Bortone, director of venture sourcing and development at JLabs. “The advancement of a JLabs company, whether they partner with Johnson & Johnson or another health care company, is a success for the industry overall.”
Following its San Diego launch, JLabs now operates seven incubators in the United States and Canada, housing 147 startups.
Access to most of JLabs is normally restricted, but we were allowed a peek inside its flagship office.
Tags: Design, Office Space, Real Estate, Startups